Astria shareholders approve BioCryst acquisition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/19/2026

1. CRWV
2. SPY
3. SLGN
4. ABBV
5. CHRD
6. VFS
7. IRON
8. EVR
9. EYPT
10. MANE

Go back to Astria shareholders approve BioCryst acquisition

Astria Stockholders Vote to Approve Acquisition by BioCryst

January 21, 2026 4:00 PM EST

BOSTON--(BUSINESS WIRE)-- Astria Therapeutics, Inc. (Nasdaq: ATXS) today announced that at the special meeting of Astrias stockholders held on January 21, 2026, Astrias stockholders voted to approve the acquisition of Astria by BioCryst Pharmaceuticals, Inc. (the Merger).

The parties expect the Merger to close on or about January 23, 2026, subject to the satisfaction of customary closing conditions.

About Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, whose mission is to bring life-changing therapies to patients and families affected by allergic and immunologic diseases. Astria's lead program, navenibart (STAR-0215), is a monoclonal... More